Search / Trial NCT06233773

The Effect of Kinesio Taping and Manual Lymph Drainage on Pregnant Women With Restless Legs Syndrome

Launched by TC ERCIYES UNIVERSITY · Jan 22, 2024

Trial Information

Current as of December 30, 2024

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how two non-drug treatments, Kinesio taping and manual lymphatic drainage, can help pregnant women who have Restless Legs Syndrome (RLS). RLS is a condition that makes people feel an uncontrollable urge to move their legs, which can cause discomfort and disrupt sleep. Since RLS can affect many aspects of a pregnant woman’s life, including her mood and ability to sleep well, finding effective treatments is very important. The goal of the study is to see if these treatments can improve the severity of RLS, help with sleep quality, and enhance overall well-being for pregnant women experiencing this condition.

To be eligible for the study, participants must be women over 18 years old, at least 13 weeks pregnant, and experiencing RLS symptoms as confirmed by a doctor. They should also be able to read and write, and have a certain level of severity in their RLS symptoms. However, women who had RLS before pregnancy, those on strict bed rest, or those with certain health issues like psychiatric conditions or severe leg problems will not be included. If chosen to participate, women can expect to receive these treatments and be monitored for any improvements in their symptoms and overall health during the trial.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Over 18 years of age,
  • Literate,
  • Gestational week 13 and above,
  • She has a singleton pregnancy,
  • Presence of RLS according to the RLS Diagnostic Criteria Questionnaire and physician examination,
  • A score of 11 or above on the RLS Severity Rating Scale,
  • Pregnant women taking iron, vitamin D, magnesium and calcium will be included in the study.
  • Exclusion Criteria:
  • Pre-pregnancy RLS,
  • Communication barriers,
  • Absolute bed rest for reasons such as cervical insufficiency, premature rupture of membranes or risk of preterm labor,
  • Have any psychiatric illness, use antipsychotic and/or antidepressant medication,
  • Acute infection of bacterial or viral origin,
  • Varicose veins in the feet and legs and severe lymphedema (circumference difference between both extremities over 5 cm),
  • Have a dermatologic problem in their feet and legs,
  • Pregnant women with rheumatic diseases such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, systemic lupus erythematosus, fibromyalgia will not be included in the study.

Trial Officials

MÜRÜVVET BAŞER, Prof. Dr.

Principal Investigator

Erciyes U

About Tc Erciyes University

TC Erciyes University is a leading academic institution in Turkey, dedicated to advancing medical research and healthcare through innovative clinical trials. With a strong emphasis on scientific excellence and collaboration, the university leverages its state-of-the-art facilities and multidisciplinary expertise to conduct rigorous studies aimed at improving patient outcomes. Committed to ethical standards and regulatory compliance, TC Erciyes University fosters a research environment that promotes the development of new therapies and interventions, contributing significantly to the global medical community.

Locations

Kayseri, Talas, Turkey

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0